Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer

Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer

Objective To analyze the relationship between the clinical parameters and the efficacy of epidermal growth factorreceptor-tyrosine kinase inhibitors (EGFR-TKIs) as the first-line therapy in patients with stage Ⅳ non-small cell lung cancer (NSCLC) and identify the clinical markers for predicting the...

Full description

Bibliographic Details
Main Authors: ZHENG Linpeng, XU Zihan, ZHU Guangkuo, LI Feng, YANG Qiao
Format: Article
Language:zho
Published: Editorial Office of Journal of Third Military Medical University 2019-02-01
Series:Di-san junyi daxue xuebao
Subjects:
non-small cell lung cancer
epidermal growth factorreceptor-tyrosine kinase inhibitors
clinical parameter
tumor biomarker
prognosis
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/201809143.htm

Internet

http://aammt.tmmu.edu.cn/Upload/rhtml/201809143.htm

Similar Items